Use of Erbium Laser for Extraction of the Third Molars
Use of Erbium Laser With the Wavelength 2.94 nm for Extraction of the Impacted Lower Third Molars
1 other identifier
interventional
60
0 countries
N/A
Brief Summary
A comparative analysis of the effectiveness of the erbium laser with the wavelength of 2.94 µm and traditional instruments in the extraction of the impacted lower third molars will be performed. Clinical, radiological and biochemical findings will be assessed after extraction of the impacted lower third molars.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable
Started Dec 2022
Typical duration for not_applicable
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
September 9, 2022
CompletedFirst Posted
Study publicly available on registry
September 14, 2022
CompletedStudy Start
First participant enrolled
December 1, 2022
CompletedPrimary Completion
Last participant's last visit for primary outcome
August 1, 2024
CompletedStudy Completion
Last participant's last visit for all outcomes
August 1, 2025
CompletedSeptember 14, 2022
September 1, 2022
1.7 years
September 9, 2022
September 9, 2022
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Assessment the level of bone regeneration according to Radiographic bone height (RBH)
Assessment the level of bone regeneration according to Radiographic bone height (RBH) by cone beam computed tomography after extraction of the lower third molar. (Radiographic bone height (RBH)- is the distance between root apex of the distal root and uppermost intersecting point between distal root of the second molar and mesial wall of extraction socket, it will be measured on the cone beam computed tomography)
Days 180 after extraction
Secondary Outcomes (14)
Radiographic bone height (RBH)
3;6 months
Radiographic infrabony defect (RID)
3;6 months
Post-operative pain
1;3;5;7;10 days
Post-operative oedema
1;3;5;7;10 days
Soft tissue epithelization
7;10;14
- +9 more secondary outcomes
Study Arms (2)
Group with impacted third molar, extracted by cutting and rotary tools
ACTIVE COMPARATORThe study group will include 28 patients with indications (impacted third molars that exerts pressure on the adjacent tooth and cause inflammation process in the surrounding tissue; absence of antagonist; pericorinitis; periodontitis; periodontal pockets) for the impacted third molar extraction. Patients will be comparable by gender and age, the patients age will be between 18 and 70 years. Patients should be with therapeutic and surgical oral hygiene and without co-morbidities.
Group with impacted third molar, extracted by erbium laser 2.94 nm
ACTIVE COMPARATORThe study group will include 28 patients with indications (impacted third molars that exerts pressure on the adjacent tooth and cause inflammation process in the surrounding tissue; absence of antagonist; pericorinitis; periodontitis; periodontal pockets) for the impacted third molar extraction.Patients will be comparable by gender and age, the patients age will be between 18 and 70 years. Patients should be with therapeutic and surgical oral hygiene and without co-morbidities.
Interventions
Extraction of the impacted lower third molar will be conducted using cutting and rotary tools under the local anesthesia (Ultracain D-S 1:100000 40 mg/ml, active substance- articaine+epinephrine, registration № П N015119/01 ). Scalpel will be used for the incision of the soft tissues, rotary instruments will be used for the bone tissue and tooth fragmentation. After the extraction the wound will be sutured by the suture material.
Extraction of the impacted lower third molar will be conducted using erbium laser with wavelength 2.94 nm under the local anesthesia (Ultracain D-S 1:100000 40 mg/ml, active substance- articaine+epinephrine, registration № П N015119/01 ). The soft tissue and bone tissue will be dissected by erbium laser with wavelength 2.94 µm (Erbium laser Smart 2940D plus with the wavelength 2,94 µm, company- DEKA, Italy, registration № 2005/1245). After the extraction the wound will be sutured by the suture material (registration № ФСЗ 2010/06040; 07.08.2018)
Eligibility Criteria
You may qualify if:
- Signing of written informed consent of the patient to participate in a study
- Age from 25 to 50 years old
- Indications for impacted third molar extraction
- Patients who are medically stable
- Therapeutic and surgical oral hygiene before surgery (absence of inflammatory diseases, caries, pulpitis, periodontitis in oral cavity)
You may not qualify if:
- Refusal of the patient from further participation in the study
- Non-compliance by the patient with postoperative recommendations
- Absence of a lower second molar
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Officials
- PRINCIPAL INVESTIGATOR
Diana Sologova
I.M. Sechenov First Moscow State Medical University (Sechenov University)
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NON RANDOMIZED
- Masking
- NONE
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
September 9, 2022
First Posted
September 14, 2022
Study Start
December 1, 2022
Primary Completion
August 1, 2024
Study Completion
August 1, 2025
Last Updated
September 14, 2022
Record last verified: 2022-09
Data Sharing
- IPD Sharing
- Will not share
No, dissemination of data is prohibited by the local ethics committee